Image Place holder

Trevor A. Rose Jr., MD, MPH


Specialty: Radiology
Program: Diagnostic Imaging and Interventional Radiology

Call 1-888-MOFFITT
(1-888-663-3488)

Call 1-888-MOFFITT
(1-888-663-3488)


Locations: Moffitt Cancer Center
Overview

Cancer Types Treated: Bladder Cancer , Kidney (Renal Cell) Cancer , Lung Cancer , Mesothelioma , Pancoast Tumor , Penile Cancer, Prostate Cancer , Testicular Cancer , Thymoma

Dr. Trevor Rose is an abdominal radiologist at Moffitt Cancer Center with a focus on clinical care and education. He attended the University of Florida for his undergraduate studies graduating with a bachelor of sciences in Microbiology. Dr. Rose attended Emory University School of Medicine where he received his medical degree in 2005. The program at Emory was a combined program where in between the third and fourth year of medical school he attended the Rollins School of Public Health where he also obtained a Masters in Public Health with a concentration in Health Policy and Management. He attended Emory University School of Medicine for his internship and radiology residency from 2005-2010. Dr. Rose completed his abdominal imaging fellowship at Emory with concentration on abdominal magnetic resonance imaging and image guided procedures. His interests include imaging of genitourinary malignancy and lung cancer.

Education & Training

Board Certification:

  • Diagnostic Radiology
  • Radiology

Fellowship:

  • Emory University - Body Imaging

Residency:

  • Emory University - Diagnostic Radiology

Medical School:

  • Emory University - MD
Participating Trials

CLINICAL TRIAL 18304
A Phase II Trial of AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer
Condition: Thoracic
Intervention: AZD1775; MK-1775 (AZD1775); Paraplatin (carboplatin); Taxol (paclitaxel); carboplatin; paclitaxel
Open

CLINICAL TRIAL 18786
A Phase 2, Randomized, Multi-institutional Study of Nivolumab and Ipilimumab versus Nivolumab, Ipilimumab and Stereotactic Body Radiation Therapy for Metastatic Merkel Cell Carcinoma
Condition: Cutaneous
Intervention: BMS-936558 (Nivolumab); Ipilimumab; Nivolumab; Yervoy (Ipilimumab)
Open

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • Luu C, Thapa R, Rose T, Woo K, Jeong D, Thomas K, Chen DT, Friedman M, Malafa MP, Hodul PJ. Identification of nonalcoholic fatty liver disease following pancreatectomy for noninvasive intraductal papillary mucinous neoplasm. Int J Surg. 2018 Oct;58:46-49. Pubmedid: 30218781.
  • John S, Antonia SJ, Rose TA, Seifert RP, Centeno BA, Wagner AS, Creelan BC. Progressive hypoventilation due to mixed CD8 and CD4 lymphocytic polymyositis following tremelimumab - durvalumab treatment. J Immunother Cancer. 2017 07;5(1):54. Pubmedid: 28716137. Pmcid: PMC5514517.
  • Rose T, Choi J. Intravenous Imaging Contrast Media Complications: The Basics That Every Clinician Needs to Know. Am J Med. 2015 Sep;128(9):943-949. Pubmedid: 25820169.
  • Rose T, Caracciolo J, Gatenby R. Cancer survivorship, a unique and growing cohort in medical practice: radiology perspective. Am J Med. 2013 Sep;126(9):759-767. Pubmedid: 23870789.